NRO Neurones SA

NEURONES: Organic growth up 5.4% in 1st quarter 2020

NEURONES: Organic growth up 5.4% in 1st quarter 2020

PRESS INFORMATION

Heading: 1st quarter 2020 revenues

Nanterre, May 6, 2020 (after the closing of the stock exchange)

Organic growth up 5.4% in 1st quarter 2020

(€ millions)Q1 2019Q1 2020growthof which organic
Revenues128.7135.3+5.1%+5.4%

Achievements

Despite the lockdown in effect since March 17, the Group achieved organic growth of +5.4% in the 1st quarter of 2020 (compared with +4.2% over the same period last year).

The operating profit (*) stood at 9.3% of revenues (compared with 9.5% for the 1st quarter of 2019 excluding exceptional capital gains).

Compared with the 2019 Universal Registration Document ( - Investors), the financial position (net cash of €218.3 million at December 31, 2019) has not changed significantly.

Outlook

Organic growth in the 1st quarter, a significant proportion of recurring managed services contracts, low exposure to affected sectors and a probable acceleration of the digital transformation constitute a favorable context. However, the fall in GDP announced at a minimum of -8% (for France) leads the Group to forecast revenues of approximately €475 million for 2020, with an operating profit of at least 6%.

In view of the current high exogenous uncertainties, this estimate is naturally less precise than those of previous years and may be revised in the light of the behavior of economic agents in the coming quarters, which is difficult to predict.

(*) unaudited and after inclusion of 0.2% expenses related to bonus shares.

About NEURONES

With 5,400 experts, the NEURONES Group specializes in Consulting (Management, Organization and Digital) and IT Services. It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD (deferred settlement) mid-caps

Press Relations:

O'Connection

Floriane Monnier

Tel.: +33 (0)6 32 37 57 28

 



NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment

EN
06/05/2020

Underlying

NRONeurones SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

NEURONES: Organic growth up 5.3% in 2nd quarter 2025 PRESS INFORMATION        Nanterre, August 6, 2025 (after trading)Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros)20242025Growthof which organicQ1204.9214.1+ 4.5%+ 3.9%Q2197.5210.2+ 6.4%+ 5.3%Total H1 revenues402.4424.3+ 5.4%+ 4.6% Achievements Organic growth of 5.3% in the second quarter was achieved in a more challenging economic environment. The most notable growth was in Data, Digital projects, market finance, ITSM (Service Now) solutions, and Business Process Management, with t...

August 6, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025 INFORMATION PRESSE        Nanterre, le 6 août 2025 (après Bourse)Rubrique : C.A. 1er semestre 2025 + 5,3% de croissance organique au 2e trimestre 2025 C.A. (en millions d’euros)20242025Croissancedont organique1er trimestre204,9214,1+ 4,5%+ 3,9%2e trimestre197,5210,2+ 6,4%+ 5,3%Total 1er semestre402,4424,3+ 5,4%+ 4,6% Réalisations A 5,3%, la croissance organique du deuxième trimestre a été réalisée dans des conditions économiques plus tendues. Les progressions les plus notables concernent la Data, les projets Digitaux, la fina...

August 6, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : Descriptif du programme de rachat d'actions

NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions                                         Nanterre, le jeudi 5 juin 2025 (après Bourse) DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS L’Assemblée Générale des actionnaires du 5 juin 2025 a renouvelé l’autorisation consentie au Conseil d’administration, pour une durée de 18 mois, de procéder à l’achat des propres actions de la société. Etabli en application de l’article 241-2 et suivants du Règlement général de l’AMF, le présent descriptif précise les modalités et les objectifs du programme d...

June 5, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025 PRESS INFORMATIONHeading: 1st quarter revenues 2025        Nanterre, May 7, 2025 (after trading) 3.9% increase in organic growth in the 1st quarter of 2025 (in millions of euros)Q1 2024Q1 2025Growthof which organicRevenues204.9214.1+ 4.5%+ 3.9% Achievements Driven by its cloud, digital and data activities, the Group's organic growth increased by 3.9% over the first three months of the year. Operating profit (*) totaled 8.2% of revenues. The increase in taxation (the fixed social security charge on bonus shares rose...

May 7, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025

NEURONES : + 3,9% de croissance organique au 1er trimestre 2025 INFORMATION PRESSERubrique : C.A. 1er trimestre 2025        Nanterre, le 7 mai 2025 (après Bourse) + 3,9% de croissance organique au 1er trimestre 2025 (en millions d’euros)T1 2024T1 2025Croissancedont organiqueChiffre d’affaires204,9214,1+ 4,5%+ 3,9% Réalisations Soutenue par le cloud, le digital et la data, la croissance organique du groupe s’établit à + 3,9% sur les trois premiers mois de l’année. Le résultat opérationnel (*) s’élève à 8,2% du chiffre d’affaires. La fiscalité en hausse (passage de 20 à 30% du forfait soci...

May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch